The compound herbal medicine Hwang-Ryun-Hae-Dok-Tang (HR; a standardized herbal formula consisting of extracts from Coptidis Rhizoma, Scutellariae Radix, Phellodendri Cortex, and Gardeniae Fructus) is used for the treatment of inflammatory disease, cerebrovascular disease, gastritis, liver disease, and hypertension. To overcome the individual differential intestinal absorption problem of oriental herbal medicine, many reports focused on bio-converted (e.g. fermentation) herbal medicines. However the interactions of drug metabolism between bio-converted herb and drug were not studied. The differences between inhibitory potentials of HR and bioconverted HR on the activity of nine major human cytochrome-P450 (CYP) enzymes in human liver microsomes were evaluated using CYP cocktail inhibition assay. HR potently inhibited CYP1A2-catalyzed phenacetin O-deethylation with 50% inhibitory concentration (IC50) values of 2.9 µM, and CYP2D6-catalyzed dextromethorphan Odemethylase with IC50 values of 25 µM. Meanwhile, bio-converted HR by HR-217, HR227 and HR-348 inhibited CYP1A2-catalyzed phenacetin O-deethylation with IC50 values of 9.2 µM, 7.2 µM and 9.0 µM, and CYP2D6-catalyzed Dextromethorphan Odemethylase with IC50 values of 263.6 µM, 34.6 µM and 29.4 µM. These in vitro results suggest that bio-converted herbal medicines should deplete potency of CYP inhibition of original herbal medicines.